Teriflunomide OverviewTeriflunomide (trade name Aubagio, marketed by Sanofi) is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010. 2-year results were positive. However, the subsequent TENERE head-to-head comparison trial reported that "although permanent discontinuations [of therapy] were substantially less common am...
Read more Teriflunomide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Teriflunomide
Recent Teriflunomide Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 14mg, 7mg
NDC Database Records for Teriflunomide: (4 results)Sorted by National Drug Code
- 68462-311 Teriflunomide 7 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
- 68462-312 Teriflunomide 14 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
- 69238-1303 Teriflunomide 7 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC
- 69238-1304 Teriflunomide 14 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC